John D Morberg
CIK 1345964 · Chief Financial Officer · last filed 2024-01-22
John D Morberg is a Chief Financial Officer who has filed 21 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for LFCR, was dated Nov 20, 2024. Across all open-market trades the lifetime net is +$215.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $798.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
LNDC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
2811 AIRPARK DRIVE
SANTA MARIA, CA 93455
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LFCR | Chief Financial Officer | 125,617 | $6.36 | $798.9K | $0 | 2 | 2024-01-22 |
| LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Chief Financial Officer | 19,400 | $8.76 | $169.9K | $215.6K | 14 | 2022-08-15 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-11-20 | LFCR | Notice (144) | −10,000 | -$71.7K | EDGAR |
| 2024-11-12 | LFCR | Notice (144) | −30,990 | -$205.8K | EDGAR |
| 2024-10-31 | LFCR | Notice (144) | −40,989 | -$232.9K | EDGAR |
| 2024-10-07 | LFCR | Notice (144) | −12,617 | -$65.5K | EDGAR |
| 2024-09-20 | LFCR | Notice (144) | −15,000 | -$82.3K | EDGAR |
| 2024-01-22 | LFCR | Mixed | +11,217 | $0 | EDGAR |
| 2023-06-05 | LFCR | Grant (A) | +95,000 | $0 | EDGAR |
| 2022-08-15 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-07-18 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-07-28 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.